Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Tighe

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Nursing Times|September 8, 1977
UrticariaS M Tighe
AORN Journal|October 1, 1985
Perioperative nursing. A survey of schoolsJ Fletcher, S M Tighe, P Vorderstrasse
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Nursing Times|September 8, 1977
UrticariaS M Tighe
AORN Journal|October 1, 1985
Perioperative nursing. A survey of schoolsJ Fletcher, S M Tighe, P Vorderstrasse
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Pageof 1